Skip to main content
. 2023 Oct 15;13(10):1498. doi: 10.3390/jpm13101498

Table 1.

Background data of patients treated by VATS and open surgery for lung cancer.

Variables VATS (n = 55) Open Surgery (n = 29) p-Value
Age (mean ± SD) 61.4 ± 8.3 58.3 ± 8.4 0.108
Age range 44–84 34–73
Gender (male, %) 23 (41.8%) 12 (41.4%) 0.969
Area of residence (urban, %) 41 (74.5%) 24 (82.8%) 0.392
Smoking status (yes, %) 20 (36.4%) 15 (51.7%) 0.174
Pack-year smoking (median, IQR) 31.5 (24.5–38.0) 33.0 (22.0–39.5) 0.548
Exposure to respiratory hazards (yes, %) 6 (10.9%) 1 (3.4%) 0.239
Blood type A (n, %) 24 (43.6%) 19 (65.5%) 0.056
CCI > 3 (n, %) 43 (78.2%) 20 (69.0%) 0.353
Comorbidities
Cardiovascular 22 (40.0%) 13 (44.8%) 0.669
Diabetes Mellitus 8 (14.5%) 3 (10.3%) 0.587
Obesity 18 (32.7%) 10 (34.5%) 0.871
CKD 5 (9.1%) 2 (6.9%) 0.729
Chronic lung disease 12 (21.8%) 7 (24.1%) 0.809
Others 4 (7.3%) 1 (3.4%) 0.481
Oncological history * 0.886
Gynecological cancer 26 (47.3%) 12 (41.4%)
Colorectal cancer 11 (20.0%) 5 (17.2%)
Urological cancer 8 (14.5%) 5 (17.2%)
Others 10 (18.2%) 7 (24.1%)

* No lung cancer history; VATS—video-assisted thoracoscopic surgery; SD—standard deviation; IQR—interquartile range; CCI—Charlson comorbidity index; CKD—chronic kidney disease.